GF Fund Management
LEGN icon

GF Fund Management’s Legend Biotech LEGN Stock Holding History

GF Fund Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$56.7K Buy
2,852
+1,064
+60% +$22.7K ﹤0.01% 376
2026
Q2 		$51.6K Sell
1,788
-93
-5% -$2.51K ﹤0.01% 386
2026
Q1 		$34K Buy
1,881
+227
+14% +$4.33K ﹤0.01% 446
2025
Q4 		$36K Sell
1,654
-158
-9% -$4.53K ﹤0.01% 438
2025
Q3 		$59.1K Sell
1,812
-280
-13% -$10.3K ﹤0.01% 377
2025
Q2 		$74.2K Hold
2,092
– – ﹤0.01% 388
2025
Q1 		$71K Buy
2,092
+377
+22% +$13.5K ﹤0.01% 389
2024
Q4 		$55.8K Buy
+1,715
New +$71K ﹤0.01% 381

Other funds holding LEGN

Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
NLB Skladi upravljanje premozenja
NLB Skladi upravljanje premozenja Ljubljana $2.71B AUM 53.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
PensionDanmark
PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Indivisible Partners
Indivisible Partners Clearwater, Florida $2.18B AUM 33.61% 1-Year Est. Return

GF Fund Management's LEGN Position: Q3 2026 in Review

GF Fund Management increased its Legend Biotech (LEGN) stake by 60% in Q3 2026, buying an estimated $22.7K and bringing the position to 2,852 shares worth $56.7K. The position accounts for ﹤0.01% of the portfolio, ranked #376.

GF Fund Management first reported a position in LEGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $74.2K in Q2 2025. 27 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • GF Fund Management held 2,852 shares of Legend Biotech worth $56.7K as of Q3 2026.
  • GF Fund Management bought 1,064 Legend Biotech shares in Q3 2026, an estimated $22.7K.
  • Legend Biotech made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #376 holding.
  • GF Fund Management first reported a position in Legend Biotech in Q4 2024 and has held it in 8 quarters since.
  • GF Fund Management's Legend Biotech position peaked at $74.2K in Q2 2025.
  • 27 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.